A Clear Vision for Professional Development
This edition of the EyeCarePD newsletter is about optical intensity and Retinal Artery Occlusions. Let’s talk about Retinal Arterial Occlusion (RAO), a vision-threatening pathology with visual outcomes ranging from 20/25 to no light perception. Even though we can often diagnosis RAO on clinical examination, adjunctive OCT imaging can still be useful. That’s because the OCT… Read More
This edition of the EyeCarePD newsletter is about retinal angiomatous proliferation and how it affects patient care. Want to learn about an interesting variant of Wet Age-Related Macular Degeneration (AMD)? Let’s talk about retinal angiomatous proliferation (RAP). Unlike choroidal neovascularization (CNV), which starts in the choroid, RAP starts in the retina. The neovessels then proliferate… Read More
This edition of the EyeCarePD newsletter is about timeframes for patient referrals for common macular pathologies. We’ve all seen patients with concerning presentations of macular disease. From blood to fluid, it can be confusing for the referring doctor to know how urgently a patient needs to be seen by a specialist. At EyeCarePD, we’re often… Read More
There just isn’t enough information out there when it comes to OCT terminology for intraretinal fluid—specifically, for the purpose of lesion classification in chorioretinal pathologies.
This edition of the EyeCarePD newsletter introduces new technology for improving the accuracy of OCT interpretation and highlights advances in the treatment of postoperative cystoid macular edema.
This edition of the EyeCarePD newsletter is about the importance of viewing macular OCT images with different contrast and background color settings.
This edition of the EyeCarePD newsletter is about the thousands of levels of intensity detected by an OCT device, as well as the difference between viewing images in pseudocolor and grayscale.
Inner retinal opacification is a common finding seen on OCTs for retinal artery occlusions.
Let’s continue the conversation about fluid. But this time, the spotlight is on intraretinal fluid.
In this newsletter, Dr. David Lederer, CEO of EyeCarePD explains why you should use the term “subretinal fluid” first, before committing to subtle differentiations.